Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CPXX

(CPXX) (CPXX) Stock Price, News & Analysis

(CPXX) logo

About (CPXX) Stock (NASDAQ:CPXX)

Advanced Chart

Key Stats

Today's Range
$30.24
$30.24
50-Day Range
N/A
52-Week Range
$1.12
$30.36
Volume
N/A
Average Volume
2.62 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.

Receive CPXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CPXX) and its competitors with MarketBeat's FREE daily newsletter.

CPXX Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

CPXX Stock Analysis - Frequently Asked Questions

(CPXX) (NASDAQ:CPXX) issued its earnings results on Tuesday, May, 10th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that (CPXX) investors own include Sophiris Bio (SPHS), Consolidated Water (CWCO), Anavex Life Sciences (AVXL), Alder Biopharmaceuticals (ALDR), Fc Global Realty (FCRE), Chipotle Mexican Grill (CMG) and Immunomedics (IMMU).

Company Calendar

Last Earnings
5/10/2016
Today
4/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CPXX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:CPXX) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners